SciELO - Scientific Electronic Library Online

 
vol.81 issue5The Production of Medline Indexed Articles on Nursing Research in Latin AmericaPost Infarction Cardiogenic Shock: Is It Clinically Important to Differentiate Hemodynamic Patterns? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista argentina de cardiología

On-line version ISSN 1850-3748

Abstract

DE ABREU, Maximiliano  and  TAJER, Carlos D.. Dual Antiplatelet Therapy Under Scrutiny: Real Benefit and Risk Subgroups. Rev. argent. cardiol. [online]. 2013, vol.81, n.5, pp.427-434. ISSN 1850-3748.

CURE, TRITON-TIMI 38 and PLATO studies have demonstrated clinical benefit with the use of dual antiplatelet therapy with clopidogrel, prasugrel or ticagrelor in addition to aspirin in patients with acute coronary syndrome, and have contributed to exponentially increased prescription. The publication of new randomized trials with findings contrasting with the benefits obtained in these studies and of some opinion articles which have questioned the validity of the results, make it necessary, at least, to rethink the general indication and actual clinical benefit of these drugs. In this article we discuss the results of these three trials as well as the methodological objections that have been posed to them, focusing on the real clinical benefit of these drugs. Likewise, the probability of prejudice in certain subgroups is discussed and a simple scheme that allows the selection of patients most likely to benefit from these treatments is postulated.

Keywords : Antiplatelets; p2y12 Receptor Antagonist; Acute Coronary Syndromes.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License